Thymulin peptide improves efficacy of Immunotherapy in aged mice
Thymulin levels in mice and humans decrease with age as levels of chronic myeloid inflammationincrease.Compared to aged mice, levels of pro inflammatory cytokines IL-1a, IL-1b, IL-6 and TNFa and were decreased in bone marrow chimeric mice. This was also observed in old mice treated with Thymulin peptide. A similar effect was observed in human PBMC
Thymulin peptide improves efficacy of Immunotherapy in aged mice Read More »
